Wire · opportunities
PearlBone from WA wins FDA approval for US orthopaedic market
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 14 November 2026 · Fusion42 review
Western Australia's Marine Biomedical secured FDA clearance for PearlBone, a first-of-its-kind bone graft substitute made from mother-of-pearl, targeting the US orthopaedic market. This regulatory milestone paves the way for clinical use in the US and potential expansion into dental and Australian markets.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can use the FDA clearance of PearlBone to enter the US orthopaedic market, but you must prepare for further regulatory and market challenges before sales begin. This approval also creates an opportunity to explore adjacent medical fields like dental implants using the same technology.
◆ Coverage
1 source · 14 Nov 2026
◆ Related on Wire
◆ Topics